Skip to main content
Cell Research logoLink to Cell Research
. 2022 Apr 4;32(6):555–569. doi: 10.1038/s41422-022-00645-7

Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons

Pingping Zhu 1,2,3,✉,#, Tiankun Lu 1,4,#, Jiayi Wu 1,5,#, Dongdong Fan 6,#, Benyu Liu 1,7, Xiaoxiao Zhu 6, Hui Guo 1, Ying Du 1, Feng Liu 8, Yong Tian 4,6,, Zusen Fan 1,4,
PMCID: PMC9160288  PMID: 35379903

Abstract

Lgr5+ intestinal stem cells (ISCs) reside within specialized niches at the crypt base and harbor self-renewal and differentiation capacities. ISCs in the crypt base are sustained by their surrounding niche for precise modulation of self-renewal and differentiation. However, how intestinal cells in the crypt niche and microbiota in enteric cavity coordinately regulate ISC stemness remains unclear. Here, we show that ISCs are regulated by microbiota and niche enteric serotonergic neurons. The gut microbiota metabolite valeric acid promotes Tph2 expression in enteric serotonergic neurons via blocking the recruitment of the NuRD complex onto Tph2 promoter. 5-hydroxytryptamine (5-HT) in turn activates PGE2 production in a PGE2+ macrophage subset through its receptors HTR2A/3 A; and PGE2 via binding its receptors EP1/EP4, promotes Wnt/β-catenin signaling in ISCs to promote their self-renewal. Our findings illustrate a complex crosstalk among microbiota, intestinal nerve cells, intestinal immune cells and ISCs, revealing a new layer of ISC regulation by niche cells and microbiota.

Subject terms: Cell biology, Intestinal stem cells

Introduction

The intestine is the largest digestive and absorptive organ, consisting of intestinal epithelium, lamina propria, muscle and so on. Intestine epithelium, the most frequently renewing organ in adult mammals, contains five kinds of mature cells, including enterocytes, goblet cells, enteroendocrine cells, Paneth cells and tuft cells.1 All these mature cells are derived from Lgr5+ intestinal stem cells (ISCs), which reside at the crypt base and harbor self-renewal and differentiation capacities.2 Many signaling pathways participate in the regulation of self-renewal and multipotency of Lgr5+ ISCs, including Wnt/β-catenin signaling, Notch signaling, BMP signaling, ErbB signaling and Hedgehog signaling.3 The self-renewal of ISCs is under precise regulation by numerous intracellular and extracellular signals. Recently, we identified an ISC-intracellular long noncoding RNA lncGata6 required for ISC self-renewal.4 The extracellular niche provides Wnt, Notch and epidermal growth factor (EGF) signals to support ISC self-renewal and normal epithelial maintenance.5,6 Numerous kinds of cells have been identified as niche cells for ISCs. In the small intestine, ISCs are interspersed between Paneth cells, which secrete critical molecules such as Wnt3, EGF, Notch, lactate and cyclic ADP ribose to maintain the stemness of ISCs.68 Stroma cells, FOXL1+ subepithelial telocytes and CD90+CD81+CD34+CD138- MAP3K2-regulated intestinal stromal cells (MRISCs) also provide Wnt and Rspo ligands as ISC niche cells.9,10 However, it is still elusive to comprehensively define ISC niche cells and niche factors.

The ISC niche contains two major components: extracellular matrix (ECM) and cellular microenvironment. The cellular microenvironment comprises all the resident cells embedded within the ECM, including pericryptal myofibroblasts, fibroblasts, pericytes, endothelial cells, immune cells, neural cells, and smooth muscle cells. These cells secrete a wide range of matrix components and growth factors for the regulation of ISC self-renewal and differentiation.11,12 Accumulating evidence demonstrates critical roles of immune cells in ISC self-renewal. For example, T cells from allogeneic transplantation mainly locate in ISC compartment and kill ISCs, which express MHC class I and II molecules.13 IL-22 secreted by group 3 ILCs (ILC3s) can promote ISC-mediated epithelial regeneration after intestinal damage, and drive ISC self-renewal.14 Recently, we revealed that ILC2 cells promote ISC self-renewal via IL-13 pathway.15

Besides immune cells, the intestinal tract contains an intrinsic nervous system that is termed as the enteric nervous system (ENS). The total number of enteric neurons is 400–600 million in human and almost equal to the number of neurons in spinal cord.16 The ENS regulates the behavior of the gut and connects to the central nervous system (CNS).17 However, it remains unclear whether nerve cells, the extremely enriched cells in intestines, can regulate ISC self-renewal. 5-hydroxytryptamine (5-HT), also known as serotonin, plays important roles in enteric neurotransmission, initiation and propagation of intrinsic enteric reflexes, gut-to-brain connections, as well as many other biological processes.18 Within the gut, 5-HT is synthesized by two types of cells, enterochromaffin (EC) cells and enteric serotonergic neurons in the myenteric plexus. The EC cells express tryptophan hydroxylase-1 (TPH1) to synthesize 5-HT and enteric serotonergic neurons express TPH2 to produce 5-HT.19 5-HT exerts its roles through engagement of 5-HT receptors. At least 14 members of 5-HT receptors have been identified up to date.20 Most members of 5-HT receptors belong to the G-protein-coupled receptor (GPCR) superfamily, and only 5-HT3 receptor belongs to the ligand-gated ion channel. Different cell types harbor specific receptors to receive 5-HT stimulation. For instance, HTR2B is highly expressed in white adipocytes and hepatocytes, and promotes lipolysis and liver gluconeogenesis during fasting.21 HTR3a is highly expressed in brown adipocytes and pancreatic β cells, and participates in systemic energy homeostasis, brown adipose tissue thermogenesis and glucose-stimulated insulin secretion.22

Intestinal epithelium is exposed to astounding numbers and diversity of microorganisms in the enteric cavity, collectively called gut microbiota.23 The gut microbiota interacts with the host extensively and regulates various physiological and pathological processes. For example, the gut microbiota can regulate innate and adaptive immunological players, including epithelial cells, antigen-presenting cells, innate lymphoid cells and regulatory T cells.24 The gut microbiota is also implicated in tumor initiation, progression and dissemination, as well as the response to cancer therapy.25 In addition, germ-free (GF) mice show a reduced epithelial cell turnover rate owing to declined proliferation of intestinal epithelial cells and declined crypt-to-tip cellular migration.2628 A recent report showed that a lactic acid-producing bacterium plays a critical role in the ISC-mediated epithelial development.29 Here, we investigated the regulatory role of microbiota–neuron crosstalk in ISC self-renewal, and found that gut microbiota metabolite valeric acid (VA) promotes 5-HT production in enteric serotonergic neurons. 5-HT signaling is required for the production of PGE2 in macrophages, which drives ISC self-renewal via engagement with its respective receptors Ep1/Ep4.

Results

Microbiota is required for the maintenance and functions of ISCs

To determine the role of intestinal microbiota in ISC regulation, we kept Lgr5GFP reporter mice in SPF (specific pathogen free) and GF conditions. We observed that GF mice displayed decreased crypt depth and Ki67+ ISC numbers (Fig. 1a). Fecal microbiota transplantation (FMT) is able to restore normal microbiota in GF mice.30 We noticed that FMT into GF mice restored the crypt depth and ISC numbers (Fig. 1a). We then conducted organoid formation assays and found that microbiota was required for ISC function both in small intestines and colons (Fig. 1b). Mice treated with ampicillin, neomycin and vancomycin (ABX) can destroy microbiota. We observed that ABX-treated mice showed substantially impaired ISC numbers and organoid formation capacity (Supplementary information, Fig. S1a, b). Through lineage tracing, we observed that GF and ABX-treated mice showed dramatically decreased ISC numbers, whereas FMT treatment into GF mice was able to rescue the self-renewal capacity of ISCs (Fig. 1c, d; Supplementary information, Fig. S1c).

Fig. 1. Microbiota promotes ISC self-renewal.

Fig. 1

a SPF mouse, GF mice and GF mice with FMT were used for ISC detection. Typical images are shown in the left panels, and statistical results of crypts (n = 100) from five mice are in the right panel. Scale bars, 50 μm. 7-day FMT treatment was used for microbiota recovery, and proper conventionalization and depletion were confirmed by RT-PCR detection of 16 S rRNA. b Organoid formation of crypts obtained from SPF mice, GF mice and GF mice with FMT. Typical images are shown in the upper panels, and organoid formation ratios and the surface area of organoid are shown in the lower panels. c SPF, GF, and FMT into GF Lgr5GFP-CreERT2; Rosa26lsl-lacZ (LRlacZ) mice were treated with tamoxifen (TAM) for lineage tracing analysis. Mice (n = 8) were sacrificed at the indicated time points and typical sections of postnatal day 65 (P65) were shown. Numbers of traced crypt-villus units (blue plots) at indicated time points were shown. d LRlacZ mice in SPF or GF states, and GF mice with FMT were treated with TAM for lineage tracing analysis. 5 days later, GFP and lacZ signals were detected by confocal microscopy. Representative images of 5 mice are shown. Scale bars, 20 μm. e SPF mice, GF mice and GF mice with FMT were treated with 10 Gy’s radiation, and sacrificed at indicated time points. Intestinal tissues were collected for H&E staining (left panel) and numbers of intact crypts were shown in the right panel (means ± SD). 20 fields from five mice were taken for each group. Scale bars, 100 μm. *P < 0.05, **P < 0.01, ***P < 0.001, by unpaired one-tailed Student’s t-test. Data were shown as means ± SD, and typical images are representative of three independent experiments.

Given the critical role of ISCs in intestinal regeneration after radiation damage,31 we then performed radiation damage followed by detection of intestinal regeneration. As expected, GF or ABX-treated mice showed dramatically impaired intestinal regeneration and repair ability (Fig. 1e; Supplementary information, Fig. S1d). These data indicate that microbiota plays a critical role in the maintenance and functions of ISCs.

Neurotransmitter 5-HT drives self-renewal of ISCs

We next wanted to explore the regulatory role of microbiota–neuron crosstalk in ISC self-renewal. To investigate whether intestinal nerve cells and neurotransmitters were involved in microbiota-mediated ISC self-renewal, we detected neurotransmitter concentrations of SPF and GF intestine tissues via mass spectrum-based metabolome analysis (Fig. 2a). We then chose top five differentially expressed neurotransmitters in GF mice and conducted in vivo blocking assays. We treated Lgr5GFP reporter mice with commercial neurotransmitter antagonists and counted GFP+ ISC numbers in intestine tissues after 3 days. We found that the tryptophan hydroxylase inhibitor pCPA most significantly decreased the ratios of ISCs in both small intestines (SI) and colons (Fig. 2b). To further test 5-HT levels in the ISC niche, we isolated stem cell niche sections via laser capture microdissection (Supplementary information, Fig. S2a). We noticed that 5-HT levels were decreased in the ISC niche fraction from GF mice (Supplementary information, Fig. S2b). In addition, mice with pCPA treatment displayed decreased depth of crypts in small intestines and colons, and shortened villi (Fig. 2c). These observations were further confirmed by probing Lgr5 in situ hybridization (Fig. 2d). Moreover, pCPA treatment attenuated the intestinal regeneration ability after radiation damage (Fig. 2e). These data suggest that 5-HT plays a critical role in the maintenance of ISCs. To distinguish central and peripheral 5-HT synthesis, we used mesenteric artery injection (MAI) to enhance intestine-specific targeting with the inhibition of brain targeting.32 We found that MAI treatment specifically blocked intestinal 5-HT synthesis but did not affect central 5-HT synthesis (Supplementary information, Fig. S2c). pCPA delivery by MAI obtained similar inhibitory effect on ISC maintenance, confirming that intestinal 5-HT is required for ISC self-renewal maintenance (Supplementary information, Fig. S2d).

Fig. 2. 5-HT drives self-renewal of ISCs.

Fig. 2

a The content of the indicated neurotransmitters in SPF and GF colon tissues were detected by mass spectrum, and normalized to the levels in SPF mice. SPF or GF mice (n = 3) were used for detection. GABA, γ-aminobutyric acid; 5-HT, 5-hydroxytryptamine; DA, dopamine; 3-MT, 3-methoxytyramine; 5-HIAA, 5-hydroxyindoleacetic acid; Ach, acetylcholine. b Two-month-old Lgr5GFP mice were treated with indicated neurotransmitters or neurotransmitter antagonists. Three days later, crypts of SI (left) and colon (right) were collected, and Lgr5GFP+ ISCs were detected by FACS. Ratios of Lgr5GFP+ ISCs in total crypt cells were shown as scatter diagram. Riluzole, glutamic acid antagonist; Primidone, GABA antagonist; pCPA, tryptophan hydroxylase inhibitor; Chlorpromazine, DA antagonist; Atractylodin, ethanolamine antagonist. Lgr5GFP mice (n = 8) for each group. c Two-month old mice were treated with 5-HT inhibitor pCPA for 36 h and 72 h, and representative H&E images of SI and colon were shown in left panel. 100 fields from five mice were observed and shown in right panel. 150 mg/kg pCPA was intraperitoneally injected. d Lgr5 in situ hybridization was performed in SI and colon tissues from pCPA-treated mice. Typical images were shown in left panel, and statistical results of 100 fields from five mice were shown in right panel. e pCPA-treated mice were treated with 10 Gy’s radiation, and sacrificed at indicated time points. Intestinal tissues were collected for H&E staining (upper panel). Numbers of intact crypts were shown in lower panel (means ± SD). Five 2-month-old mice were used and 20 fields were taken for each group. 150 mg/kg pCPA was intraperitoneally injected. f Sert KO SI and colon crypts were collected for ISC detection by FACS. Lgr5GFP; Sert+/+ (Sert+/+) or Lgr5GFP; Sert/ (Sert−/−) mice (n = 8) were used and the ratios of Lgr5GFP+ ISCs were shown. g LRlacZ mice were crossed with Sert−/− mice, followed by administration of TAM for lineage tracing analysis through intestinal whole-mount staining for β-gal. 200 μL TAM in sunflower oil (10 μg/μL) was intraperitoneally injected. 7 mice were sacrificed at indicated time points and typical sections of P65 were shown. h LRlacZ;Sert−/− mice were used for lineage tracing analysis, and intestinal tissues were stained for lacZ. n = 7 mice per group. For ce, scale bars, 100 μm. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant; statistics was performed by unpaired one-tailed Student’s t-test. At least three independent repeats were performed for each experiment and the representative results were shown.

In addition, we found that 5-HT injection largely restored 5-HT levels and ISC numbers in SI and colon tissues of GF mice (Supplementary information, Fig. S2e, f). Serotonin transporter (SERT) can recycle 5-HT to terminate its action, and Sert deficient mice showed increased 5-HT levels.33 We generated Sert-knockout (KO) mice (Supplementary information, Fig. S2g, h). Sert-deficient mice displayed increased 5-HT levels in ISC niche and decreased 5-HT levels in myenteric neurons (Supplementary information, Fig. S2i, j). We found that Sert-KO mice showed increased length of villi and crypts (Supplementary information, Fig. S2k). In addition, Sert-KO also increased ISC numbers in both small intestines and colons (Fig. 2f). To further perform lineage tracing, LR lacZ;Sert−/− mice were established by crossing Sert KO mice with Lgr5GFP-CreERT2 and Rosa26lsl-lacZ mice. We observed that Sert deletion increased ISC numbers and intestinal renewal ability (Fig. 2g, h; Supplementary information, Fig. S2l). Altogether, 5-HT promotes the self-renewal maintenance of ISCs.

5-HT produced by enteric serotonergic neurons is required for ISC self-renewal

5-HT metabolism is a complicated process and numerous enzymes are involved in this process (Supplementary information, Fig. S3a). We examined expression levels of serotonin-metabolism-related genes and found Tph1/2 were downregulated in GF mice (Supplementary information, Fig. S3b). Within the gut, 5-HT is generated by EC cells and enteric serotonergic neurons of myenteric plexus. The EC cells contain tryptophan hydroxylase-1 (TPH1) responsible for biosynthesis of 5-HT, whereas enteric serotonergic neurons express TPH2 for 5-HT production.34 To determine the source cells for 5-HT production, we generated Tph1-KO mice and obtained Tph2-KO mice (Supplementary information, Fig. S3c–e). We next detected 5-HT levels of total tissues and ISC niche fractions in Tph1-KO and Tph2-KO mice, and found a remarkable decrease of 5-HT in ISC niche in Tph2-KO mice (Supplementary information, Fig. S3f). We found that Tph2-KO mice displayed much shorter crypts and villi and reduced numbers of ISCs, whereas Tph1-KO mice showed normal ISCs compared to littermate wild-type (WT) mice (Fig. 3a; Supplementary information, Fig. S3g). These observations were further validated by staining for another ISC marker Olfm4 and proliferation marker Ki67 antigen (Fig. 3b, c). Moreover, Tph2 KO mice also showed impaired intestinal regeneration post-radiation damage (Fig. 3d). Of note, 5-HT was an essential factor for ISC function in Tph2−/− mice via 5-HT injection assay (Supplementary information, Fig. S3h). Additionally, peripheral TPH2+ cells were required for ISC maintenance through mesenteric artery injection of 5-HT to Tph2-KO mice (Supplementary information, Fig. S3i–k).

Fig. 3. 5-HT generated by enteric serotonergic neurons contributes to ISC self-renewal.

Fig. 3

a Lgr5 in situ hybridization was performed in SI and colon tissues from Tph1- and Tph2-KO mice. Typical image were shown in left panel, and 100 fields from five mice were observed and shown in right panel. Scale bars, 100 μm. b, c Lgr5GFP;Tph1−/− mice and Lgr5GFP;Tph2−/− mice were sacrificed on P60 and intestine tissues were collected for immunofluorescence staining by indicated antibodies. Typical images of small intestine (b) and large intestine (c) are shown. 100 fields from five mice were observed and calculated. Scale bars, 50 μm. d Tph1 and Tph2 KO mice were treated with 10 Gy’s radiation, and sacrificed at indicated time points. Intestinal tissues were collected for H&E staining (upper panel) and numbers of intact crypts were shown in lower panel (means ± SD). 20 fields from five mice were taken for each group. Scale bars, 100 μm. e Fluorescence staining of intestinal tissue from 2-month-old Lgr5GFP, Lgr5GFP;Tph1DTR and Lgr5GFP;Tph2DTR mice 6 days after the first diphtheria toxin (DT) treatment. 100 ng/mouse DT treatments were performed on day 0 and day 3. 100 fields from five mice were observed. Scale bars, 50 μm. f LRlacZ;Tph1DTR and LRlacZ;Tph2DTR mice were treated with 100 ng/mouse DT every 3 days, and used for lineage tracing analysis, and intestinal tissues were stained for lacZ observation. 6 mice were used. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired one-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired one-tailed Student’s t-test; ns, not significant. At least three independent repeats were performed for each experiment and the representative results were shown.

To further verify the role of EC cells and enteric serotonergic neurons in ISC self-renewal, we generated Tph1DTR and Tph2DTR mice through CRISPR/Cas9 approaches, in which EC cells and enteric serotonergic neurons will be depleted upon diphtheria toxin (DT) treatment (Supplementary information, Fig. S3l–n). As expected, decreased ISC numbers and impaired ISC function could be observed in DT-treated Tph2DTR mice, whereas DT-treated Tph1DTR mice had normal ISC number and normal function compared to Lgr5GFP mice (Fig. 3e, f). 5-HT was an essential factor for ISC function in DT-treated Tph2DTR mice (Supplementary information, Fig. S3o). Moreover, depletion of Tph2+ enteric serotonergic neurons caused impaired ISC maintenance and decreased ISC gene expression (Supplementary information, Fig. S3p–r). These observations confirm that enteric serotonergic neurons play a critical role in ISC self-renewal and intestinal regeneration. Taken together, enteric serotonergic neurons are required for ISC self-renewal and intestinal regeneration.

Microbiota metabolite VA initiates Tph2 expression by inhibiting recruitment of the NuRD complex

In many cases, microbiota secretes metabolites to participate in the regulation of biological processes.35 We then used absorbable metabolites to treat GF mice and examined Tph2 expression levels in intestinal tissues.36 Of these metabolites we examined, VA could dramatically promote Thp2 expression in GF mice, while other metabolites we used had no such effect (Fig. 4a; Supplementary information, Table S1). We treated Lgr5GFP mice with other short chain fatty acids (SCFAs), and found only VA promoted expression of Tph2 and ISC signature genes (Supplementary information, Fig. S4a). The observation that Tph2 expression was enhanced by VA was further validated by immunoblotting (Fig. 4b). In addition, VA could promote expression of ISC proliferation-related genes in GF intestine (Fig. 4b). Moreover, VA treatment was able to enhance 5-HT generation in GF myenteric plexus, similar with FMT treatment (Fig. 4c; Supplementary information, Fig. S4b). Of note, FMT and VA treatment could augment ISC-related gene expression and restore ISC numbers, but failed to do so in the Tph2-deleted mice, suggesting FMT and VA promoted ISC self-renewal in a TPH2-dependent manner (Fig. 4d, e). A recent report showed that Megasphaera massiliensis is a source to produce VA.37 We then transferred Megasphaera massiliensis to SPF or GF mice via intragastric administration. We found that Megasphaera massiliensis administration increased VA levels in intestines of GF and SPF mice (Supplementary information, Fig. S4c, d), consequently promoted expression of ISC signature genes and proliferation genes (Supplementary information, Fig. S4e). Neuron depletion in Tph2DTR mice confirmed the essential role of serotonergic neurons in the microbiota and VA-mediated ISC maintenance (Fig. 4f, g). Similarly, ABX inhibited ISC maintenance in a TPH2-dependent manner (Supplementary information, Fig. S4f). Collectively, VA secreted by microbiota promotes Tph2 expression and 5-HT-mediated ISC self-renewal.

Fig. 4. VA reduces enrichment of the NuRD complex onto Thp2 promoter to initiate its expression.

Fig. 4

a GF mice were treaded with indicated metabolites, and Thp2 in intestine tissues was detected by RT-PCR. SPF and Ex-GF mice were used for positive controls. 6 mice were treated with metabolites daily for 5 days per group. Ex-GF mice denote conventional mice which were exited from GF condition. b Total intestine tissues from treated mice were lyzed for western blot. β-actin was used as a loading control. 3 mice were detected with similar results. VA, valeric acid. c Myenteric plexus was isolated from treated mice, and 5-HT was detected by confocal microscopy. Typical images and 5-HT+ ratios were shown. 20 fields from five mice were taken for each group. Blue, DAPI; Red, 5-HT. Scale bars, 50 μm. d SI and colon tissues from treated Tph2 KO and control mice were used for RT-PCR analysis. ISC marker genes (Olfm4, Ascl2, Lgr5) were detected and normalized to the levels of SPF mice. 6 mice were detected per group. e SI and colon crypts were obtained from treated Tph2-KO and control mice, and ISCs were detected by FACS. 6 mice per group. f, g Tph2DTR mice were treated with DT for serotonergic neuron depletion, followed by ISC markers and ISC ratio detection as in d, e. h Silver staining of eluate from CAPTURE assay using SPF-, GF- or VA-treated myenteric plexus cells. Increased bands in GF cells were identified as HDAC1, HDAC2 and MBD3. i The interaction of Tph2 promoter with HDAC1, HDAC2, and MBD3 in indicated myenteric plexus was detected by CAPTURE assay and Western blot. j Indicated myenteric plexus cells were obtained for ChIP assay against HDAC1, HDAC2, and MBD3. Enrichment of Thp2 promoter (−3600~−3400 region) was examined by RT-PCR. k Enteric serotonergic neurons were sorted by TPH2 and confirmed by 5-HT staining, followed by FISH for Tph2 promoter detection and immunofluorescence staining for HDAC1. Ratios of co-localized cells in enteric serotonergic neurons isolated from indicated treatment mice were shown. 3 mice were used per panel, and 100 cells were observed per mouse. l H4K5ac, H3K9ac, and H3K4me3 modifications of Thp2 promoter were detected by ChIP assay. −3600~−3400 region of Thp2 promoter were detected by RT-PCR. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. Statistics was performed by unpaired one-tailed Student’s t-test. At least three independent repeats were performed for each experiment and the representative results were shown.

To further explore the molecular mechanism of microbiota-mediated Tph2 expression, we isolated myenteric plexus cells from GF mice and SPF mice, and examined chromatin accessibility of Tph2 promoter by DNase protection assay. We found that the −3600~−3400 region of Tph2 promoter was resistant to DNase digestion in GF mice, suggesting the Tph2 promoter is suppressed in GF mice (Supplementary information, Fig. S4g). The activation of Tph2 promoter by VA was validated by luciferase assay (Supplementary information, Fig. S4h). HDAC1, HDAC2 and MBD3, which are main components of the NuRD complex that inhibits gene transcription,38 were identified as protein candidates for binding Tph2 promoter in GF cells through CAPTURE assay (Capture of Chromatin Interactions by Biotinylated dCas9)39 (Fig. 4h; Supplementary information, Fig. S4i). Enhanced interaction of Tph2 promoter with these three components was confirmed by Western blot. However, FMT and VA treatment blocked the interaction of NuRD complex with Tph2 promoter (Fig. 4i). These observations were further confirmed by chromatin immunoprecipitation (ChIP) and fluorescence in situ hybridization (FISH) assays (Fig. 4j, k; Supplementary information, Fig. S4j). These data suggest that FMT and VA treatment can reduce the enrichment of the NuRD complex onto Tph2 promoter. H3K5ac and H3K9ac are two histone H3 modifications that are removed by HDAC1/2.40 H3K4me3 is an active marker for gene transcription activation.41 We found that FMT and VA treatment enriched H3K5ac, H3K9ac and H3K4me3 onto Tph2 promoter region (Fig. 4l). To further examine the direct or indirect role of VA in 5-TH production and release, we established in vitro culture system of myenteric plexus neurons.42 We observed that VA treatment increased Tph2 expression (Supplementary information, Fig. S4k, l) and promoted 5-HT levels (Supplementary information, Fig. S4m). In addition, blocking the NuRD complex activity impaired VA-mediated 5-HT production, further confirming that VA directly regulates Tph2 expression through the NuRD complex (Supplementary information, Fig. S4k–m). Altogether, VA inhibits enrichment of the NuRD complex onto Tph2 promoter to initiate its expression.

5-HT activates Ptges expression in macrophages

We next explored the molecular mechanism of 5-HT in ISC self-renewal. First, we established organoid formation assay with ISC, crypt or ISC plus CD45+ cells, and found 5-HT mainly activated ISC self-renewal through CD45+ cells (Fig. 5a, b; Supplementary information, Fig. S5a, b). Among top10 downregulated genes in Tph2-deficient CD45+ cells, Ptges, a critical gene for PGE2 expression, was required for CD45+ cells-dependent ISC self-renewal (Fig. 5c, d). Of note, Ptges-KO mice showed decreased numbers of ISCs in both small intestines and colons (Fig. 5e; Supplementary information, Fig. S5c, d). Moreover, pCPA treatment impaired ISC function in WT mice, but not in Ptges-KO mice, indicating an essential role of Ptges in 5-HT-mediated ISC self-renewal and function (Fig. 5e). A previous study showed that fibroblasts is a key PGE2 producer in the intestinal stem cell niche.43 We then treated recipient mice with 10 Gy’s irradiation, and performed bone marrow transplantation to compare differential functions of stromal and myeloid PGE2 (Supplementary information, Fig. S5e). In SPF condition, WT bone marrow transplant into Ptges-KO mice promoted expression of ISC signature genes and proliferation genes, and non-myeloid cells (stromal cells) also participated in ISC activation. In contrast, myeloid cells showed impaired role in ISC activation and stromal cells played a predominant role in GF condition (Supplementary information, Fig. S5f).

Fig. 5. 5-HT functions through macrophages.

Fig. 5

a, b Organoid formation of ISC and crypt (a), or ISCs co-cultured with CD45+ cells (b). Organoid formation medium was supplemented with or without 5 μM 5-HT. 4 mice were used for organoid formation. c Heat map of Tph2-KO and control CD45+ cells, with top10 low expressed genes in Tph2 knockout cells listed in right. Red, high expression; Blue, low expression. d Organoid formation ratios of ISCs co-cultured with CD45+ immune cells in which indicated genes were silenced individually, supplemented with 5 μM 5-HT. Results are from 4 independent experiments. e ISC ratios of Ptges+/+ and Ptges/− mice, which were treated with 150 mg/kg pCPA 3 days before ISC detection. 5 mice were used for ISC detection. f RT-PCR analysis for Ptges expression in indicated cells isolated from Tph2+/+ and Tph2/− mice. 3 Tph2+/+ and Tph2−/− mice were used. g Lgr5 in situ hybridization in SI and colon tissues of macrophage-depleted mice, which were intraperitoneally injected with CSF1R ab (antibody, 10 mg/kg). 100 fields from five mice were taken for each group. Scale bars, 50 μm. h FACS detection for ISC ratios in SI and colon crypts from indicated treated mice. For each group, 5 Tph2DTR mice were treated with 100 ng DT every 3 days (twice), and adoptively transferred with 2 × 106 macrophage cells (Mφ). Mφ were activated by 5 μM 5-HT for 8 h and ISCs were detected 2 days after Mφ adoptive transfer. i Organoid formation of ISCs, co-cultured with WT or Ptges-KO macrophages and 5 μM 5-HT. n = 6 mice were used for each group. j Lgr5 in situ hybridization was performed in small intestine from the indicated mice. Scale bars, 50 μm. k CSF1R antibody (ab) treated and control small intestine crypts were collected for ISC detection by FACS. 5 mice were used per group and ratios of ISCs were shown. l The indicated mice were treated with 10 Gy’s radiation, and sacrificed at 5 days after radiation. Intestinal tissues were collected for H&E staining (upper panel) and numbers of intact crypts were shown in lower panel (means ± SD). n = 20 fields from five mice were taken for each group. Scale bars, 100 μm. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired one-tailed Student’s t-test. At least three independent repeats were performed for each experiment and the representative results were shown.

Ptges was widely expressed in CD45+ immune cells, and especially macrophages, which exhibited 5-HT dependent Ptges expression (Fig. 5f). Indeed, macrophage depletion largely decreased ISC numbers in both small intestines and colons (Fig. 5g). Adoptive transfer of WT macrophages, but not Ptges−/− macrophages, was able to rescue ISC numbers in Tph2-depleted mice (Fig. 5h), indicating that 5-HT exerts its role in ISC self-renewal mainly through PGE2 in macrophages. Similarly, in organoid formation assays, 5-HT-promoted ISC self-renewal required PGE2+ macrophage activation (Fig. 5i). We next cultured myenteric plexus neurons from WT and Tph2-KO mice with or without macrophages for organoid formation assay.42 We observed that Tph2-KO myenteric plexus neurons impaired organoid formation in a macrophage-dependent manner (Supplementary information, Fig. S5g).

We also examined the role of macrophages in 5-HT-mediated ISC maintenance. We noticed that none of microbiota, VA or 5-HT affected ISC numbers in macrophage-depleted mice (Fig. 5j, k; Supplementary information, Fig. S5h, i). Moreover, macrophage-depleted mice showed impaired intestinal regeneration post-radiation damage, and microbiota-VA-5-HT axis failed to regulate the intestinal regeneration upon macrophage depletion (Fig. 5l). These results indicate that intestinal macrophages are required for the 5-HT-mediated ISC maintenance.

5-HT promotes PEG2 expression in PGE2+ macrophages via engagement with its receptors HTR2A and HTR3A

5-HT exerts its role through its cognate receptors, so we next detected the expression patterns of 5-HT receptors on macrophages. We silenced each receptor in macrophages and detected the role of 5-HT in Ptges expression. We noticed that Htr2a or Htr3a knockdown decreased Ptges expression, whereas knockdown of other 5-HT receptors had no significant inhibition (Fig. 6a). Indeed, Htr2a and Htr3a were highly expressed in macrophages (Fig. 6b). Moreover, blockade of HTR2A and HTR3A with their inhibitors Ketanserin and Tropisetron suppressed 5-HT-dependent PGE2 production (Fig. 6c). We then generated Htr2a and Htr3a KO mice, and established double KO (DKO) mice by crossing these KO mice (Supplementary information, Fig. S6a–d). Decreased PGE2 release was observed in Htr2a and Htr3a KO macrophages (Fig. 6d). These data suggest that HTR2A and HTR3A are required for 5-HT-dependent PGE2 production. More importantly, Htr2a and Htr3a KO mice showed decreased numbers of ISCs, indicating the essential role of Htr2a and Htr3a in ISC maintenance (Fig. 6e).

Fig. 6. 5-HT promotes PGE2 expression with engagement with its receptors HTR2A and HTR3A.

Fig. 6

a RT-PCR detection of Ptges expression levels in 5-HT treated intestinal macrophages, in which the indicated 5-HT receptors were silenced individually. 2 × 105 indicated silenced intestinal macrophages were treated with 5 μM 5-HT for 8 h, and Ptges expression was detected 24 h later. Results are from 3 independent assays. Htr knockdown efficiency was confirmed by RT PCR. b High expression of Htr2a and Htr3a in intestinal macrophage cells, which were enriched via FACS. c PGE2 production in macrophages treated with indicated inhibitors of 5-HT receptor. 10 μg/mL Ketanserin and 25 μg/mL Tropisetron were used and 3 independent experiments were performed. d ELISA detection for PGE2 production in microphages, which were sorted from 5-HT treated Htr2a KO, Htr3a KO, or DKO mice. All PGE2 levels were normalized to those of Vehicle treated mice (n = 3 per group). e Fluorescence staining of intestinal tissue from 2-month-old Lgr5GFP, Lgr5GFP; Htr2a−/, Lgr5GFP; Htr3a/, and Lgr5GFP; Htr2a−/−; Htr3a/ mice. 100 fields from five mice were observed. f, g FACS detection for ISC ratios in SI or colon tissues from dmPGE2-treated (f) or indomethacin (Indo)-treated (g) mice. 5 mg/kg dmPGE2, 10 mg/kg indo and 150 mg/kg pCPA were intraperitoneally injected and 5 mice were used per group. h Organoid formation of ISCs, supplemented with/without 1 μM dmPGE2. Typical organoid images of three independent assays were shown. i PGE2 expression was analyzed in CSF1R+ macrophage cells, which were obtained from SI tissues of SPF, GF, GF + FMT, and GF + VA mice. 5 mice were used for each group. Typical FACS results were shown in the left panel, and PGE2+ macrophage ratios were in the right panel. j PGE2+ macrophages were isolated from ileum tissues of CD45.1 mice, and transferred to Lgr5GFP mice, and SI tissue location of CD45.1+ macrophages was shown. 2 × 106 live PGE2+ macrophages were used for each mouse. k PGE2+ macrophage-transfer assay was performed to GF-Lgr5GFP mice and DT-treated Lgr5GFPTph2DTR mice, and ISC ratios were measured with FACS. SI and colon tissues were measured. n = 5 mice per group. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired one-tailed Student’s t-test; ns, not significant.

We then examined PGE2 function in ISC self-renewal. PGE2 treatment increased ISC numbers, whereas PGE2 inhibitor indomethacin treatment decreased ISC numbers (Fig. 6f, g). In addition, PGE2 treatment promoted organoid formation of ISCs (Fig. 6h), suggesting a critical role of PGE2 in ISC self-renewal. Intriguingly, we found that PGE2 was enriched in a subpopulation of macrophages, and the ratios of PGE2+ macrophages were decreased in GF mice, whereas FMT and VA treatment restored the ratios of PGE2+ macrophages (Fig. 6i; Supplementary information, Fig. S6e, f). We used FACS to analyze CD45.1 cell numbers and their intracellular levels of PGE2 in transfer assays. We observed that macrophages mainly distributed in the host SI (Supplementary information, Fig. S6g). PGE2 levels in transferred macrophages were comparable to WT mice when ISCs were detected two days post transfer (Supplementary information, Fig. S6h, i).

Previous reports revealed that surface markers CX3CR1 and P2RX4 are required for PGE2 production in macrophages.44,45 We observed that PGE2+ cells highly expressed CX3CR1 and P2RX4 (Supplementary information, Fig. S7a). Moreover, CX3CR1hi P2RX4+ cells were able to generate PGE2, but not CX3CR1int, CX3XR1neg, or CX3CR1hi P2RX4- cells (Supplementary information, Fig. S7b, c), We concluded that CX3CR1hi P2RX4+ cells were related to the PGE2+ macrophage subset. We also confirmed that CX3CR1hiP2RX4+ cells were regulated by microbiota and metabolite VA (Supplementary information, Fig. S7d, e). It has been reported that intestinal macrophages are either from embryonic precursors or adult bone marrow-derived monocytes.46 Based on our bone marrow transplant assay, we found that PGE2+ bone marrow could generate PGE2+ macrophages that maintained the self-renewal of ISCs (Supplementary information, Fig. S5e, f), suggesting that PGE2+ macrophages are bone marrow-derived. A previous report showed that intestinal macrophages contain two groups, lamina propria macrophages (LpMs) and muscularis macrophages (MMs).47 We noticed that PGE2+ macrophages both distributed in muscularis and lamina propria (new Supplementary information, Fig. S7f, g).

We then isolated PGE2+ and PGE2- macrophages for adoptive transfer. We found that more PGE2+ macrophages distributed in ISC niche than PGE2- macrophages (Fig. 6j; Supplementary information, Fig. S7h). In myenteric plexus, PGE2+ macrophages were mainly localized near zones with high 5-HT content (Supplementary information, Fig. S7i). We also simultaneously showed the presence of enteric serotonergic neurons, PGE2+ macrophages and ISCs, and confirmed that PGE2+ macrophages existed in both myenteric plexus (near serotonergic neurons) and lamina propria (near ISCs) (Supplementary information, Fig. S7j). In addition, adoptive transfer of PGE2+ macrophages dramatically restored ISC ratios in GF mice and serotonergic neuron-depleted mice (Fig. 6k). These results suggest that PGE2+ macrophages are involved in the ISC self-renewal maintenance. Finally, we observed that 5-HT activated NF-kB signaling pathway to initiate Ptges expression (Supplementary information, Fig. S7k–n). Altogether, 5-HT activates PGE2 production through its cognate receptors HTR2A and HTR3A on macrophages.

PGE2 promotes ISC self-renewal through Wnt/β-catenin signaling

The mechanism of PGE2 in ISC self-renewal is not clear. We silenced all four PGE2 receptors in our in vitro organoid formation assays. We found that knockdown of Ep1 or Ep4 remarkably suppressed organoid formation (Fig. 7a). We next generated EP1 and EP4 knockout mice, and these mice displayed shorter crypts and villi, and DKO mice showed much shorter crypts and villi than each single KO mice (Fig. 7b; Supplementary information, Fig. S8a–d). Expectedly, Ep1, Ep4 KO mice and DKO mice showed decreased ISC numbers (Fig. 7c, d). These results indicate that PGE2 signaling mediated by EP1 and EP4 is required for the ISC maintenance. In addition, DKO mice displayed impaired intestinal regeneration after radiation damage (Fig. 7e). Reduced ISC stemness was further validated by lineage tracing assays (Fig. 7f). To further determine cell-autonomous act of EP1 and EP4 in ISC regulation, we isolated WT, Ep1−/−, Ep4−/− and DKO ISCs, supplemented with dmPGE2 or macrophages plus 5-HT for organoid formation. We found both EP1 and EP4 function in an ISC-intrinsic manner (Supplementary information, Fig. S8e). We then transferred WT macrophages to Ep1−/− and Ep4−/− mice and found WT macrophages could not rescue ISC phenotype in these two KO mice (Supplementary information, Fig. S8f). Collectively, PGE2 signaling is initiated by engagement with its receptors EP1 and EP4 to maintain ISC stemness.

Fig. 7. PGE2 drives Wnt signaling activation to maintain ISC stemness.

Fig. 7

a Organoid formation assay of indicated PGE2 receptor-silenced ISCs, supplemented with 1 μM dmPGE2. Results are from  5 independent experiments. b H&E staining of SI and colon of WT, Ep1/, Ep4−/−, and DKO mice. Typical images were shown in left panel and 100 fields from five mice were observed in right panel. Scale bars, 50 μm. c FACS detection for ISC ratios in SI and colon crypt, which were from WT, Ep1/−, Ep4/, and DKO mice. 5 mice per group. d Fluorescence staining of intestinal tissue from 2-month-old Lgr5GFP, Lgr5GFP; Ep1/, Lgr5GFP; Ep4/ and Lgr5GFP; Ep1−/; Ep4/ mice. 100 fields from five mice were observed. Scale bars, 50 μm. e WT and DKO mice were treated with 10 Gy’s radiation, and sacrificed at indicated time points, and typical images were shown. 20 fields from five mice for each group. Scale bars, 100 μm. f Lgr5GFP-CreERT2; Rosa26lsl-lacZ (LRlacZ) mice were crossed with DKO mice, and intestinal whole-mount staining of β-gal was performed for lineage tracing analysis. 8 mice were observed for each group and typical sections were shown. P60, postnatal day 60; TAM, tamoxifen. g Heatmap of indicated Wnt/β-catenin target genes in WT and DKO ISCs. 3 mice were used per group. h WT and DKO mice were crossed with Axin2lacZ mice. SI and colon tissues were stained for β-gal expression. β-gal staining indicates the activation of Wnt/β-catenin signaling. Typical images of 5 mice were shown. Scale bars, 50 μm. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired one-tailed Student’s t-test. At least three independent repeats were performed for each experiment and the representative results were shown.

Considering the crosstalk between PGE2 and Wnt/β-catenin signaling, we next detected Wnt/β-catenin activation. We noticed that DKO ISCs showed reduced inhibition o Wnt/β-catenin signaling activation (Fig. 7g; Supplementary information, Fig. S8g, h). In addition, we crossed DKO mice with Axin2lacZ mice and found that DKO ISCs displayed impaired Wnt/β-catenin activation (Fig. 7h). These data indicate that PGE2 signaling promotes Wnt/β-catenin signaling activation. Taken together, PGE2 promotes ISC self-renewal through Wnt/β-catenin signaling.

Discussion

Under homeostatic conditions, the intestinal epithelium harbors remarkable self-renewal capacity that is driven by ISCs residing within specialized niches at the crypt base.48 The self-renewal of ISCs is under precise regulation by various intracellular and extracellular signals. In this study, we showed that neurotransmitter 5-HT and PGE2 are required for the self-renewal maintenance of ISCs and intestinal regeneration. PGE2+ macrophages serve as crypt niche cells, which promote Wnt/β-catenin signaling in ISCs through engagement with PGE2 receptors EP1/EP4. VA produced by gut microbiota promotes Tph2 expression in the enteric serotonergic neurons through suppression of recruitment of the NuRD complex. Our work reveals the crosstalk between microbiota, enteric neurons, immune cells and intestinal stem cells, adding a new layer for intestinal homostastasis regulation. Of note, treatment with FMT or VA does not completely restore PGE2+ macrophage frequencies in GF mice, suggesting that there might be an alternative mechanism that contributes to the phenotype. The precise mechanisms of development and cell fate determination of PGE2+ macrophage subset need to be further investigated.

The intestinal 5-HT is generated by two types of cells, EC cells and enteric serotonergic neurons of the myenteric plexus, respectively being synthesized by rate-limiting enzymes TPH1 and TPH2.34 The 5-HT generated by the EC cells overflows to gastrointestinal lumen and blood. Overflowing 5-HT from the EC cells is taken up and concentrated in platelets as a sole source of blood 5-HT. It has been reported that the 5-HT generated by the enteric serotonergic neurons mediates fast and slow excitatory neurotransmission and regulates gastrointestinal motility.49 Gross’s work showed that Tph2−/− (but not Tph1−/−) mice display decreased crypt depth and impaired crypt proliferation, and Sert−/− mice show an opposite effect.33 To our knowledge, little is known whether and how the neuronal 5-HT and Tph2+ enteric serotonergic neurons regulate ISC function. In our study, we identified 5-HT as a novel niche factor and Tph2+ neurons as a novel niche cell subpopulation to regulate ISCs, and also provided a full mechanism from Tph2 expression by valeric acid to the ISC function mediated by neuronal 5-HT.

5-HT exerts its functions through engagement with 5-HT receptors, including 13 distinct heptahelical GPCRs and one ligand-gated ion channel.20 5-HT and its receptors are identified to exist in both the central and peripheral nervous system, and they are also present in non-neuronal tissues such as gut, cardiovascular system and blood. Here, we found that Htr2a and Htr3a are highly expressed on macrophages and these receptors mediate the effect of 5-HT signaling on PGE2 production. Upon 5-HT engagement, these receptors activate Ptges expression, which induces PGE2 production. PGE2 further promotes Wnt/β-catenin activation and ISC self-renewal through EP1 and EP4. As one of the most important pathways in stem cells, Wnt/β-catenin is modulated precisely. We have identified several modulators in Wnt regulation,5052 and here we have revealed 5-HT-PGE2-Wnt axis in ISC self-renewal. A recent work showed that a subset of PTGER4-expressing intestinal macrophages (PTGER4+ intestinal macrophages) is a driver of epithelial regeneration during recovery upon intestinal inflammation, serving as niche cells of ISCs, but macrophage specific PTGER4 deficiency has no impact on gut homoeostasis.53 Here, we show that Ep1 and Ep4 are highly expressed on ISCs and Ep1/Ep4 DKO impairs ISC self-renewal maintenance. We conclude that EP1 and EP4 function in an ISC-intrinsic manner.

Intestinal macrophages play critical roles in intestinal development, homeostasis, regeneration, aging, pathogen infection as well as inflammation.46,54 Intestinal macrophages are a kind of tissue resident macrophages, and their functions are also finely regulated by various tissue factors. Increasing evidence indicates the critical role of macrophages in intestinal stem cells. CSF1R blockade causes a decrease of Lgr5+ ISCs and aberrant differentiation of intestinal epithelial cell lineages.55 AhR ablation in intestinal macrophages also disturbs intestinal epithelium development.56 Macrophages secrete hepatocyte growth factor to promote ISC self-renewal and differentiation.57 Here we reveal a novel mechanism of intestinal macrophages in ISC self-renewal. Intestinal macrophages serve as signal transmitting cells in a neuro-immune-stem cell regulatory circuit, and modulate ISC self-renewal by upstream enteric serotonergic neurons. Intestinal macrophages express Htr2a and Htr3a, which are required for the initiation of 5-HT signaling from enteric serotonergic neurons. Engagement of 5-HT with its receptors Htr2a/3a in intestinal macrophages promote Ptges expression and PGE2 release, which drives the self-renewal of ISCs via Wnt/β-catenin pathway. Besides intestinal macrophages, some 5-HT receptors are also expressed in intestinal epithelial cells,58 whose exact roles in the self-renewal of ISCs still need to be further investigated.

Gut microbiota plays critical roles in host health and disease, whose modulations mainly depend on direct stimulation by bacterial cell components and the effects of bacterial metabolites.59 The bacterial cell components affect the physiological and pathological functions of the immune system via the direct stimulation of Toll-like receptors (TLRs) expressed by dendritic cells and colonocytes in the colonic mucosa.60 Only a few of bacterial metabolites such as short-chain fatty acids (SCFA) have been defined,61 most of them are not well known yet. Here we demonstrate only VA drives expression of Tph2 and ISC signature genes. A recent report showed that many bacterial metabolites can be absorbed by colonocytes and into somatic blood,36 indicating the critical roles of bacterial metabolites in the regulation of host health and disease. Kaiko et al. reported that many bacterial metabolites suppress ISC self-renewal in the organoid formation assay.62 Here we showed that the gut microbiota and metabolite VA are required for ISC self-renewal and intestinal regeneration. Moreover, VA can inhibit enrichment of the NuRD complex onto Tph2 promoter, thus initiating Tph2 expression, which promotes 5-HT production in enteric serotonergic neurons. In our study, we demonstrate that the bacterial metabolite VA can induce ISC self-renewal by an in vivo lineage tracing assay. The differences between Kaiko et al. and our findings suggest that specific bacterial metabolites may have different roles in the regulation of intestinal homeostasis and regeneration. Our work adds a new layer of ISC regulation by niche enteric nervous system, enteric immune cells and gut microbiota.

Different segments of intestines and colons differ in microbe levels. In this study, we focus on the ileum and colon, which show similar phenotypes. We show that injected Megasphaera massiliensis was distributed in both ileum and colon section. As for the segment distributions of other microbes, it needs to be further investigated. The link between gut microbiota and intestinal epithelium homeostasis is a fascinating field, and increasing studies reveal “microbiota–epithelium” crosstalks such as “fungal metabolite–macrophage–epithelium integrity” axis63 and “lactic acid-producing bacteria–lactic acid–intestinal stem cell–epithelial development” axis.29 Lee et al revealed that lactic acid-producing bacteria promote the ISC-mediated epithelial development via lactic acid receptor GPR81, which is expressed on Paneth and stromal cells.29 However, little is known about the crosstalk between microbiota and intestinal nerve cells, and the effect of “microbiota–nerve” crosstalk on the stemness regulation of ISCs. Herein, we reveal novel niche factors (including microbiota metabolite VA and neurotransmitter 5-HT) and niche cells (enteric serotonergic neurons, PGE2+ macrophages) for ISC self-renewal maintenance, which provides an additional layer for ISC regulation.

Materials and Methods

Antibodies and reagents

Anti-Olfm4 (#14369), anti-EPCAM (#14452) and anti-E-Cadherin (#8437S) antibodies were from Cell Signaling Technology. Anti-GFP (#ab183735), anti-Ki67 (#ab15580), and anti-Digoxin (#ab51949) antibodies were obtained from Abcam. Anti-WGA (#GTX01500) antibody was purchased from GeneTex. Anti-β-catenin (#610154) antibody was obtained from BD Biosciences. Anti-Krt20 (#17329-1-AP) antibody was purchased from Proteintech. Streptavidin-conjugated CD45 antibody (#AC12-0147-22) was from Abcore. Biotin-conjugated PGE2 antibody (#EU2554) was from Fine Biotech. Anti-PGE2 (#ab2318) antibody was from Abcam. HRP-conjugated secondary antibodies were from Sungene Biotech. Alexa-594, Alexa-488, and Alexa-647-conjugated anti-rabbit and anti-mouse secondary antibodies were purchased from Invitrogen. OpalTM 7-color fIHC kit (#MEL797001KT) was from PerKinElmer. Polymer HRP detection kits were from GBI labs. N2 supplement and B27 supplement were from Invitrogen. Wnt3a, RSPO1, Noggin and EGF proteins were purchased from Peprotech. N2 and B27 were from Invitrogen. 4’,6-diamidino-2-phenylindole (DAPI), N-acetylcysteine, Y27632 and hyaluronidase were from Sigma-Aldrich. Riluzole, Primidone, pCPA, and Atractylodin were purchased from MedChemExpress (MCE). Chlorpromazine was obtained from Selleck Chemicals.

Generation of knockout mice by CRISPR/Cas9 technology

Sert/−, Tph1/−, Htr2a/−, Htr3a−/−, Ptges−/−, Ptger1−/−, Ptger4−/−, Tph1DTR, and Tph2DTR mice were generated using CRISPR/Cas9 approaches as described.64 Approximate 250 zygotes in C57BL/6 background were injected with corresponding sgRNAs (Supplementary information, Table S2) and subsequently transferred to the uterus of pseudo-pregnant ICR females, from which viable founder mice were obtained. Tph2-KO mice were obtained from Feng Liu Lab. All mouse genotypes were verified by DNA sequencing. Other gene-modified mouse strains were: Rosa26lsl-Cas9 mice were purchased from the Jackson Laboratory. Lgr5GFP-CreERT2 mice were obtained from Model Animal Research Center of Nanjing University. Rosa26YFP mice were purchased from Shanghai Biomodel Organism Science & Technology Development Co., Ltd. Rosa26lacZ mice were from Shanghai Bioray Laboratory. Axin2lacZ and Apcmin/+ mice were from Nanjing Biomedical Research Institute of Nanjing University. All the mouse strains were C57BL/6 background and maintained under specific pathogen free conditions with approval by the Institutional Committee of Institute of Biophysics, Chinese Academy of Sciences. The study is compliant with all relevant ethical regulations regarding animal research. For TAM injection, 200 μL TAM in sunflower oil (10 μg/μL) was intraperitoneally injected into Lgr5CreERT2 mice at 60 days old.

All SPF mice, including WT C57BL/6, were bred and housed in a barrier facility accredited by the Institutional Committee of Institute of Biophysics, Chinese Academy of Sciences and Zhengzhou University. GF C57BL/6 J mice were maintained in GF conditions in vinyl isolators in the animal facility of Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and were used according to protocols approved by the Institutional Committee of Institute of Biophysics, Chinese Academy of Sciences.

Tyramide signal amplification for FISH

For multiple-color staining, OpalTM 7-color fIHC kit was used according to the manual. Briefly, intestine paraffin sections were sequentially stained with Anti-GFP, anti-Krt20, anti-Ki67, anti-OLFM4 and anti-E-Cad primary antibodies, and HRP-conjugated secondary antibodies. One of the six Opal reagents were used for staining, followed by microwave treatment and another round staining. Opal520, Opal540, Opal570, Opal620, Opal650, Opal690 dyes were used for staining. Samples were visualized using Vectra Automated Quantitative Pathology Imaging System (PerkinElmer).

Organoid culture and co-culture

For intestinal organoid culture, murine intestines were digested by 0.1% type-I collagenase (Invitrogen), and further incubated in 1× TrypLE express (Life Technologies) supplemented with 0.8 kU/mL DNaseI (Roche) for single cell preparation. Lgr5+ cells were sorted using FACS. Intestinal organoid medium was used as previously described with minor modifications.2 Briefly, Dulbecco’s modified Eagle’s medium/F12 medium (Invitrogen) was supplemented with 20 ng/mL EGF (Peprotech), 100 ng/mL Noggin, N2 (Invitrogen), B27 (Invitrogen), 1.25 mM N-acetylcysteine (Sigma-Aldrich), 1 mg/mL Rspo1 (peprotech), 20 mM Y27632 (Sigma-Aldrich). Medium was replaced every 2 days and pictures of organoids were taken 1 week later. For ISC-immune cell co-culture, ISC and CD45+ immune cells were co-cultured at ratio 1:10, and cultured ISC medium supplemented with 1000 U/mL murine IL-2, 10 ng/mL murine IL-15, 50 ng/mL murine IL-7 and 5 μM 5-HT.

Isolation of intestinal macrophages and enteric serotonergic neurons

For intestinal macrophage isolation, small intestines were washed with three times with PBS, and then were opened longitudinally, cut into 1-cm pieces, and incubated in PBS supplemented with 5 uM EDTA, 5%FBS and 1 mM DTT. Then the samples were digested with 0.14 U/mL Liberase (Sigma) for 30 min at 37 °C on a rotor. The digested cell suspension was then passed through 70 mm cell strainers, followed by FACS staining and CD11b+F480+CX3CR1+ intestinal macrophages were sorted via FACS Aria III (BD).

For enteric serotonergic neuron isolation, myenteric plexus was isolated and dissociated in M199 medium (Invitrogen) containing 1.1 mg/mL collagenase, 50 U/mL DNase I, 0.1% BSA, 1 mM CaCl2, 20 mM Hepes for 40 min at 37 °C. Then single cells were fixed, penetrated and stained with Tph2 antibody, and Tph2+ serotonergic neuron can be sorted by FACS.

β-galactosidase staining for ISC tracing

For ISC tracing, 60-day-old Lgr5GFP-IRES-CreERT2; Rosa26lsl-lacZ (LRlacZ) mice were intraperitoneally injected with 2 mg TAM in sunflower oil (10 μg/μL). On day 61, day 63, day 65 and day 90, 8 mice in one group were sacrificed and intestine tissues were obtained for β-galactosidase staining (Beyotime Biotechnology, #RG0039). Briefly, intestines were incubated in fixation buffer (RG0039-1) at room temperature for 20 min and then washed with PBS. Samples were incubated in staining buffer (including 10 μL buffer A, 10 μL buffer B, 930 μL buffer C and 50 μL X-Gal) at 37 °C for 30 min, and the samples were then screened by EPSON ImageScanner III. Finally the traced units were counted.

Treatment with neurotransmitter antagonists and metabolites

For neurotransmitter analysis, Lgr5GFP mice were intraperitoneally injected with neurotransmitter antagonists according to standard dosages (Riluzole, 25 mg/kg; Primidone, 100 mg/kg; pCPA, 150 mg/kg; Chlorpromazine 5 mg/kg; Atractylodin 1 mg/kg), and crypts of small intestine and colon were collected for ISC detection.

For neurotransmitter analysis, GF mice were treaded with indicated metabolites daily for 5 days, followed by Tph2-detection. The dosages are determined as previously described: VA, 50 mg/kg; Pipecolic acid, 250 mg/kg; sarcosine, 300 mg/kg; 1, 4-MeImAA, 20 mg/kg; 5-Aminovaleric acid, 20 mg/kg; Trimethylamine Noxide, 20 mg/kg; S-Lactoylglutathione, 50 mg/kg; Adenine, 50 mg/kg; Prostaglandin E2, 1 mg/kg; N-Acetylglutamic acid, 150 mg/kg; N-Acetylornithine, 50 mg/kg; Betaine aldehyde, 30 mg/kg.

In situ hybridization and FISH

For Lgr5 in situ hybridization, mouse Lgr5 gene was cloned into PCDNA4 plasmid and in situ probes targeting 1 kb N-terminal fragment of mouse Lgr5 were labeled with Digoxin through in vitro transcription.65 Intestinal sections were rehydrated, treated with 0.2 M HCl and proteinase K solution, and then incubated in acetic anhydride solution, followed by hybridization overnight at 68 °C with Lgr5 probes in hybridization buffer (5× standard saline citrate (SSC, pH 4.5), 2% blocking powder (Roche), 50 μg/mL yeast transfer RNA, 50% formamide, 5 mmol/L ethylenediaminetetraacetic acid, 0.05% 3[3-cholaminopropyl diethylammonio]-1-propane sulfonate, 50 μg/mL heparinm, 0.1% Tween 20). Samples were then rinsed in 2× SSC and washed with 2× SSC/50% formamide at 60 °C for 3 × 20 min. Then sections were blocked for 30 min in TBST containing 0.5% blocking powder (Roche), followed by overnight incubation at 4 °C in blocking solution with HRP-conjugated anti-digoxigenin (1:2000 dilution; Roche).

CRISPR affinity purification in situ of regulatory elements

CRISPR affinity purification in situ of regulatory elements (CAPTURE) assay was performed to as described.39,66 Briefly, pEF1a-BirA-V5-neo (Addgene #100548) pEF1a-FB-dCas9-puro (Addgene #100547) and Tph2 promoter were overexpressed for intracellular dCas9 biotinylation and purified with Streptavidin, and the enrichment of Tph2 promoter binding proteins were identified through silver staining and mass spectrum, and confirmed by western blot.

Western blot

ISCs or myenteric plexus cells were lyzed with RIPA buffer (150 mM NaCl, 0.1% SDS, 1% NP40, 0.5% sodium deoxycholate, 1 mM EDTA, 50 mM Tris, pH 8.0) and separated with SDS-PAGE. Then samples were then transferred to NC membrane (Beyotime Biotechnology, Shanghai, China) and incubated with primary antibodies. After washing with TBST three times, membranes were incubated with HRP-conjugated secondary antibodies for visualization.67

PGE2 secretion assay

We established PGE2 secretion assay to sort viable PGE2+ cells. Streptavidin-conjugated CD45 antibody (Abcore, #AC12-0147-22) and Biotin-conjugated PGE2 antibody (Fine Biotech, #EU2554) were mixed at a mole ratio of 1:1 for 10 min, and then subjected to the incubation with samples and the PGE2-catching antibody was attached to CD45+ immunocytes. The cells were then placed in 37 °C for 45 min to facilitate PGE2 secretion, and then samples were labeled with another PGE2 antibody (Abcam, #ab2318) for PGE2 detection. Other antibodies could also be used for co-staining for FACS or immunofluorescence.

Macrophage depletion

For macrophage depletion, 200 μg neutralizing antibodies to CSF1R (#M279; Amgen) or control rat IgG were administered intraperitoneally every 3 days for 1 month. Efficiency of macrophage depletion was confirmed by FACS 3 days after antibody injection, and then ISC numbers and functions were analyzed.

ChIP

ChIP was performed according to the standard protocol (Upstate Biotechnology, Inc.). Briefly, myenteric plexus cells were fixed in 1% formaldehyde for 10 min at 37 °C, and then cracked by SDS lysis buffer for 10 min on ice, followed by ultrasonic to shear DNA into fragments between 200 bp and 500 bp. Anti-HDAC1, anti-HDAC2, anti-H4K5ac, anti-H3K9ac, and anti-H3K4me3 antibodies were used for ChIP assays as described.68

TOPFLash

TOPFlash assay was used for Wnt/β-catenin activation detection. TOPFlash (Plasmid #12456, Addgene) and FOPFlash (Plasmid #12457, Addgene) were transfected into ISCs (1 × 105) along with thymidine kinase through electroporation, followed by 36 h incubation in organoid formation medium. Then cells were lyzed and detected using substrates L and S (Promega dual luciferase kit). Wnt/β-catenin activation was measured by fold changes of TOPFlash versus FOPFlash as control.

Realtime PCR

Total RNA was extracted from ISCs or myenteric plexus cells, and used for reverse transcription PCR (RT-PCR). Complement DNA (cDNA) was used as templates for realtime PCR.69 Sequence-specific primers for detected genes were listed in Supplementary information, information, Table S3.

Co-immunoprecipitation (co-IP) assay

For co-IP, samples were lyzed with RIPA buffer for 30 min at 4 °C and precipitate was removed from cell lysates by centrifugation at 12,000 × g for 10 min. Supernatants were pre-cleared by protein A/G beads (Santa Cruz Biotechnology) for 1 h, and anti-HTR1B, anti-Axin1 or anti-β-catenin antibody was added for 4 h incubation. New protein A/G beads were added for immunoprecipitation. Precipitates were collected and examined by estern blot with indicated antibodies.

Statistics and reproducibility

For statistical evaluation, an unpaired Student’s t-test was applied for calculating statistical probabilities in this study. For all panels, at least three independent experiments were performed with similar results, and representative experiments are shown. Data were analyzed by GraphPad Prism 5.0. Kaplan–Meier survival analysis was performed by SPSS 20.0. All flow cytometry data were analyzed with FlowJo 10 (Treestar). Adobe Photoshop CC 14.0 and ImageJ 1.48 were used for figure presentation. One-tailed unpaired Student’s t-test was performed using Excel 2010. P-values ≤ 0.05 were considered significant (*P < 0.05; **P < 0.01; ***P < 0.001); non-significant (NS), P > 0.05.

Supplementary information information

Figure S1 (1.5MB, docx)
Figure S2 (1.7MB, docx)
Figure S3 (2.7MB, docx)
Figure S4 (1.9MB, docx)
Figure S5 (2.2MB, docx)
Figure S6 (5.3MB, docx)
Figure S7 (3.4MB, docx)
Figure S8 (3MB, docx)
Table S1 (12.9KB, xlsx)
Table S2 (9.1KB, xlsx)
Table S3 (11.1KB, xlsx)

Acknowledgements

We thank Drs. Yihui Xu and Yan Teng for technical support. We thank Zixin Zhao, Zheng Liu, Jiajia Hou, Xinyi Wu, Ke Zhang and Xing Gao for providing GF and SPF mouse strains.We thank the staff of the Antibody Engineering Laboratory in Core Facility for Protein Sciences (Institute of Biophysics, CAS). We thank Jing Li (Cnkingbio Company Ltd, Beijing, China) for technical support. This work was supported by the National Key R&D Program of China (2020YFA0803501, 2019YFA0508501), the National Natural Science Foundation of China (31922024, 31930036, 82173176, 32170874, 31870883, 81921003, 92042302, 91940305, 82130088, 31771638, 31870883), and Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203). We are thankful for the supportinggrants from Zhengzhou University to P.Z. and the technical support from Modern Analysis and Computer Center of Zhengzhou University.

Author contributions

P.Z. designed and performed experiments, analyzed data, and wrote the paper; J.W. and T.L. performed experiments and analyzed data; D.F. and X.Z. generated genome modified mice; F.L. provided Tph2 KO mice; B.L., H.G., and Y.D. performed some experiments; Y.T. initiated and analyzed data; Z.F. initiated the study, organized, designed, and wrote the paper.

Data availability

All other data supporting the findings of this study are available from the corresponding author on reasonable request.

Competing interests

The authors declare no competing interests.

Footnotes

The original online version of this article was revised: Figure 1 was replaced with an updated version.

These authors contributed equally: Pingping Zhu, Tiankun Lu, Jiayi Wu, Dongdong Fan.

Change history

11/4/2022

A Correction to this paper has been published: 10.1038/s41422-022-00734-7

Contributor Information

Pingping Zhu, Email: zhup@zzu.edu.cn.

Yong Tian, Email: ytian@ibp.ac.cn.

Zusen Fan, Email: fanz@moon.ibp.ac.cn.

Supplementary information, information

The online version contains supplementary material available at 10.1038/s41422-022-00645-7.

References

  • 1.Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat. Rev. Gastro. Hepat. 2019;16:19–34. doi: 10.1038/s41575-018-0081-y. [DOI] [PubMed] [Google Scholar]
  • 2.Sato T, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265. doi: 10.1038/nature07935. [DOI] [PubMed] [Google Scholar]
  • 3.Hu, D., Yan, H., He, X. C. & Li, L. Recent advances in understanding intestinal stem cell regulation. F1000Research8, 16793.1 (2019). [DOI] [PMC free article] [PubMed]
  • 4.Zhu PP, et al. LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis. Nat. Cell Biol. 2018;20:1134–1145. doi: 10.1038/s41556-018-0194-0. [DOI] [PubMed] [Google Scholar]
  • 5.Barker N, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007. doi: 10.1038/nature06196. [DOI] [PubMed] [Google Scholar]
  • 6.Sato T, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418. doi: 10.1038/nature09637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rodriguez-Colman MJ, et al. Interplay between metabolic identities in the intestinal crypt supports stem cell function. Nature. 2017;543:424–435. doi: 10.1038/nature21673. [DOI] [PubMed] [Google Scholar]
  • 8.Yilmaz OH, et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature. 2012;486:490–495. doi: 10.1038/nature11163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shoshkes-Carmel M, et al. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature. 2018;557:242–254. doi: 10.1038/s41586-018-0084-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wu N, et al. MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche. Nature. 2021;592:606–610. doi: 10.1038/s41586-021-03283-y. [DOI] [PubMed] [Google Scholar]
  • 11.McCarthy N, Kraiczy J, Shivdasani RA. Cellular and molecular architecture of the intestinal stem cell niche. Nat. Cell Biol. 2020;22:1033–1041. doi: 10.1038/s41556-020-0567-z. [DOI] [PubMed] [Google Scholar]
  • 12.Santos AJM, Lo YH, Mah AT, Kuo CJ. The intestinal stem cell niche: homeostasis and adaptations. Trends Cell Biol. 2018;28:1062–1078. doi: 10.1016/j.tcb.2018.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fu YY, et al. T cell recruitment to the intestinal stem cell compartment drives immune-mediated intestinal damage after allogeneic transplantation. Immunity. 2019;51:90–102. doi: 10.1016/j.immuni.2019.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lindemans CA, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560–564. doi: 10.1038/nature16460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhu P, et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3. Nat. Immunol. 2019;20:183–194. doi: 10.1038/s41590-018-0297-6. [DOI] [PubMed] [Google Scholar]
  • 16.Spencer NJ, Hu HZ. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat. Rev. Gastro. Hepat. 2020;17:338–351. doi: 10.1038/s41575-020-0271-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Margolis, K. G., Cryan, J. F. & Mayer, E. A. The microbiota-gut-brain axis: from motility to mood. Gastroenterology160, 1486–1501 (2021). [DOI] [PMC free article] [PubMed]
  • 18.Sahu A, et al. The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network. J. Cell Commun. Signal. 2018;12:731–735. doi: 10.1007/s12079-018-0482-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gutknecht L, Kriegebaum C, Waider J, Schmitt A, Lesch KP. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur. Neuropsychopharm. 2009;19:266–282. doi: 10.1016/j.euroneuro.2008.12.005. [DOI] [PubMed] [Google Scholar]
  • 20.Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002;71:533–554. doi: 10.1016/s0091-3057(01)00746-8. [DOI] [PubMed] [Google Scholar]
  • 21.Sumara G, Sumara O, Kim JK, Karsenty G. Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab. 2012;16:588–600. doi: 10.1016/j.cmet.2012.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Crane JD, et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 2015;21:166–172. doi: 10.1038/nm.3766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat. Rev. Gastro. Hepat. 2019;16:35–56. doi: 10.1038/s41575-018-0061-2. [DOI] [PubMed] [Google Scholar]
  • 24.Jiao, Y. H., Wu, L., Huntington, N. D. & Zhang, X. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases. Front. Immunol. 11 e282 (2020). [DOI] [PMC free article] [PubMed]
  • 25.Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastro. Hepat. 2019;16:690–704. doi: 10.1038/s41575-019-0209-8. [DOI] [PubMed] [Google Scholar]
  • 26.Sommer F, Backhed F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 2013;11:227–238. doi: 10.1038/nrmicro2974. [DOI] [PubMed] [Google Scholar]
  • 27.Savage DC, Siegel JE, Snellen JE, Whitt DD. Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl. Environ. Microbiol. 1981;42:996–1001. doi: 10.1128/aem.42.6.996-1001.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Alam M, Midtvedt T, Uribe A. Differential cell kinetics in the ileum and colon of germfree rats. Scand. J. Gastroentero. 1994;29:445–451. doi: 10.3109/00365529409096836. [DOI] [PubMed] [Google Scholar]
  • 29.Lee YS, et al. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development. Cell Host Microbe. 2018;24:833–846. doi: 10.1016/j.chom.2018.11.002. [DOI] [PubMed] [Google Scholar]
  • 30.Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ. Clinical application and potential of fecal microbiota transplantation. Annu. Rev. Med. 2019;70:335–351. doi: 10.1146/annurev-med-111717-122956. [DOI] [PubMed] [Google Scholar]
  • 31.Metcalfe C, Kljavin NM, Ybarra R, de Sauvage FJ. Lgr5(+) stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell. 2014;14:149–159. doi: 10.1016/j.stem.2013.11.008. [DOI] [PubMed] [Google Scholar]
  • 32.Porvasnik, S. L, Mah, C., & Polyak, S. Targeting murine small bowel and colon through selective superior mesenteric artery injection. Microsurgery30, 487–493 (2010). [DOI] [PubMed]
  • 33.Gross ER, Gershon MD, Margolis KG, Gertsberg ZV, Cowles RA. Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology. 2012;143:408–417. doi: 10.1053/j.gastro.2012.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gershon MD, Tack J. The serotonin signaling system: From basic understanding to drug development-for functional GI disorders. Gastroenterology. 2007;132:397–414. doi: 10.1053/j.gastro.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 35.Chen HW, et al. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell. 2019;177:1217–1231. doi: 10.1016/j.cell.2019.03.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Matsumoto M, et al. Colonic absorption of low-molecular-weight metabolites influenced by the intestinal microbiome: a pilot study. PLoS One. 2017;12:e0169207. doi: 10.1371/journal.pone.0169207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Luu M, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat. Commun. 2021;12:4077. doi: 10.1038/s41467-021-24331-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zhang Y, et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 1999;13:1924–1935. doi: 10.1101/gad.13.15.1924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Liu X, et al. In situ capture of chromatin interactions by biotinylated dCas9. Cell. 2017;170:1028–1043. doi: 10.1016/j.cell.2017.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ekwall K. Genome-wide analysis of HDAC function. Trends Genet. 2005;21:608–615. doi: 10.1016/j.tig.2005.08.009. [DOI] [PubMed] [Google Scholar]
  • 41.Benayoun BA, et al. H3K4me3 breadth is linked to cell identity and transcriptional consistency. Cell. 2015;163:1281–1264. doi: 10.1016/j.cell.2015.10.051. [DOI] [PubMed] [Google Scholar]
  • 42.Brun P, Akbarali HI. Culture of neurons and smooth muscle cells from the myenteric plexus of adult mice. Methods Mol. Biol. 2018;1727:119–125. doi: 10.1007/978-1-4939-7571-6_9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Roulis M, et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. Nature. 2020;580:524–529. doi: 10.1038/s41586-020-2166-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Grainger JR, et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat. Med. 2013;19:713–721. doi: 10.1038/nm.3189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ulmann L, Hirbec H, Rassendren F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 2010;29:2290–2300. doi: 10.1038/emboj.2010.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.De Schepper S, et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell. 2019;176:676–676. doi: 10.1016/j.cell.2019.01.010. [DOI] [PubMed] [Google Scholar]
  • 47.Gabanyi I, et al. Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell. 2016;164:378–391. doi: 10.1016/j.cell.2015.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat. Rev. Mol. Cell Bio. 2014;15:19–33. doi: 10.1038/nrm3721. [DOI] [PubMed] [Google Scholar]
  • 49.Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin. Chim. Acta. 2009;403:47–55. doi: 10.1016/j.cca.2009.01.028. [DOI] [PubMed] [Google Scholar]
  • 50.Chen Z, et al. LncFZD6 initiates Wnt/beta-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. Oncogene. 2018;37:3098–3112. doi: 10.1038/s41388-018-0203-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chen Z, Yao L, Liu Y, Zhu P. LncTIC1 interacts with beta-catenin to drive liver TIC self-renewal and liver tumorigenesis. Cancer Letters. 2018;430:88–96. doi: 10.1016/j.canlet.2018.05.023. [DOI] [PubMed] [Google Scholar]
  • 52.Zhu P, et al. lnc-beta-Catm elicits EZH2-dependent beta-catenin stabilization and sustains liver CSC self-renewal. Nat. Struct. Mol. Biol. 2016;23:631–639. doi: 10.1038/nsmb.3235. [DOI] [PubMed] [Google Scholar]
  • 53.Na YR, et al. Prostaglandin E2 receptor PTGER4-expressing macrophages promote intestinal epithelial barrier regeneration upon inflammation. Gut. 2021;70:2249–2260. doi: 10.1136/gutjnl-2020-322146. [DOI] [PubMed] [Google Scholar]
  • 54.Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat. Rev. Gastro. Hepat. 2019;16:531–543. doi: 10.1038/s41575-019-0172-4. [DOI] [PubMed] [Google Scholar]
  • 55.Sehgal, A. et al. The role of CSF1R-dependent macrophages in control of the intestinal stem-cell niche. Nat. Commun. 9, 1272 (2018). [DOI] [PMC free article] [PubMed]
  • 56.Chng SH, et al. Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity. Sci. Rep. 2016;6:23820. doi: 10.1038/srep23820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.D’Angelo F, et al. Macrophages promote epithelial repair through hepatocyte growth factor secretion. Clin. Exp. Immunol. 2013;174:60–72. doi: 10.1111/cei.12157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Glatzle J, et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology. 2002;123:217–226. doi: 10.1053/gast.2002.34245. [DOI] [PubMed] [Google Scholar]
  • 59.Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastro. Hepat. 2020;17:223–237. doi: 10.1038/s41575-019-0258-z. [DOI] [PubMed] [Google Scholar]
  • 60.Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009;9:313–323. doi: 10.1038/nri2515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kim CH, Park J, Kim M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Network. 2014;14:277–288. doi: 10.4110/in.2014.14.6.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Kaiko GE, et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell. 2016;165:1708. doi: 10.1016/j.cell.2016.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chikina AS, et al. Macrophages maintain epithelium integrity by limiting fungal product absorption. Cell. 2020;183:411–428. doi: 10.1016/j.cell.2020.08.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhu, X. X. et al. An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 System. Sci Rep. 4, 6420 (2014). [DOI] [PMC free article] [PubMed]
  • 65.Chen Zhenzhen, Benyu L. Identification of cis-HOX-HOXC10 axis as a therapeutic target for colorectal tumor-initiating cells without APC mutations. Cell Rep. 2021;36:109431. doi: 10.1016/j.celrep.2021.109431. [DOI] [PubMed] [Google Scholar]
  • 66.Chen Z, et al. circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF. J. Clin. Invest. 2021;131:e148020. doi: 10.1172/JCI148020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Zhu PP, et al. LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat. Commun. 2016;7:13608. doi: 10.1038/ncomms13608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Zhu PP, et al. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells. J. Clin. Invest. 2015;125:3795–3808. doi: 10.1172/JCI81979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Chen ZZ, et al. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat. Commun. 2016;7:12598. doi: 10.1038/ncomms12598. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1 (1.5MB, docx)
Figure S2 (1.7MB, docx)
Figure S3 (2.7MB, docx)
Figure S4 (1.9MB, docx)
Figure S5 (2.2MB, docx)
Figure S6 (5.3MB, docx)
Figure S7 (3.4MB, docx)
Figure S8 (3MB, docx)
Table S1 (12.9KB, xlsx)
Table S2 (9.1KB, xlsx)
Table S3 (11.1KB, xlsx)

Data Availability Statement

All other data supporting the findings of this study are available from the corresponding author on reasonable request.


Articles from Cell Research are provided here courtesy of Nature Publishing Group

RESOURCES